There are 3 papers on CKMT2 activity in aging research: 1 observational study in people, 2 in animals.
3 papers study it4 findings
1 new paper in 30 daysSee all 3 papers on CKMT2 activity
“CKMT2 was lower in cases (pooled Hedges’ g = −0.60, p = 0.006)”
- Humans1
- Animals2
Interventions
1Resistance training
no changein humans1
1 study
Resistance training
no changein humans1
Resistance training showed no clear effect on CKMT2 activity in humans (Paired biopsies).
“it was unchanged by 6 months of resistance training in 72 donors with paired biopsies.”
Human trialPaired biopsiesskeletal muscle6 monthsn = 72
Omics : a journal of integrative biology
Effects
1Case discrimination
no changein silico1
1 study
Case discrimination
no changein silico1
CKMT2 activity showed no clear effect on case discrimination in silico After adjustment for mitochondrial content and fiber-type composition (AUC: 0.77–0.49).
“Its discrimination did not survive adjustment for mitochondrial content and fiber-type composition (area under the curve [AUC]: 0.77–0.49)”
In silicoAfter adjustment for mitochondrial content and fiber-type compositionskeletal muscle
Omics : a journal of integrative biology
Associations
2Oxidative phosphorylation
downin humans1
1 study
Oxidative phosphorylation
downin humans1
CKMT2 activity is associated with oxidative phosphorylation in humans (Lower CKMT2).
“Single-nucleus analysis linked lower CKMT2 to reduced oxidative phosphorylation and attenuated contractile programs.”
HumansLower CKMT2skeletal muscle
Omics : a journal of integrative biology
Sarcopenia
downin humans1
1 study
Sarcopenia
downin humans1
CKMT2 activity is associated with sarcopenia in humans (Lower expression in cases; deficit depended on case definition) (Pooled Hedges’ g = −0.60; sarcopenia-defined cohorts g = −1.01; frailty-defined cohorts g = −0.27).
“CKMT2 was lower in cases (pooled Hedges’ g = −0.60, p = 0.006)”
HumansLower expression in cases; deficit depended on case definitionvastus lateralisn = 268
Omics : a journal of integrative biology